Literature DB >> 8464728

In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

K Rittner1, C Burmester, G Sczakiel.   

Abstract

The rate of double strand formation between procaryotic antisense RNA and complementary RNA in vitro is known to correlate with the effectiveness of antisense RNA in vivo. In this work, an in vitro assay for determining the hybridization rates of a large number of antisense RNA species was developed. A set of HIV-1-directed antisense RNAs with the same 5'-end but successively shortened 3'-ends was produced by alkaline hydrolysis of a 150 nt HIV-1-directed antisense transcript. This mixture was used to determine hybridization rates for individual chain lengths with a complementary HIV-1-derived RNA in vitro. The second order binding rate constants of individual antisense RNA species differed by more than a factor of 100, although in some cases, slow-hybridizing and fast-hybridizing antisense RNAs differed by only two or three 3'-terminally-located nucleotides. The results indicated that there was not a trivial dependence of binding rates on the chain length of antisense RNAs. Further, the binding rate constants determined in vitro for individual antisense RNA species correlated with the extent of inhibition of HIV-1 replication in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464728      PMCID: PMC309322          DOI: 10.1093/nar/21.6.1381

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

Review 1.  The role of antisense RNA in gene regulation.

Authors:  P J Green; O Pines; M Inouye
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  Antisense DNA and RNA: progress and prospects.

Authors:  J Walder
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

Review 4.  Structure and function of nuclear and cytoplasmic ribonucleoprotein particles.

Authors:  G Dreyfuss
Journal:  Annu Rev Cell Biol       Date:  1986

Review 5.  Plasmid incompatibility.

Authors:  R P Novick
Journal:  Microbiol Rev       Date:  1987-12

Review 6.  An approach to chemotherapy based on base sequence information and nucleic acid chemistry. Matagen (masking tape for gene expression).

Authors:  P O Ts'o; P S Miller; L Aurelian; A Murakami; C Agris; K R Blake; S B Lin; B L Lee; C C Smith
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

7.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

8.  Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1.

Authors:  K Rittner; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

Review 9.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

10.  Control of ColE1 plasmid replication: enhancement of binding of RNA I to the primer transcript by the Rom protein.

Authors:  J Tomizawa; T Som
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

View more
  22 in total

Review 1.  Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes.

Authors:  C D Blair; Z N Adelman; K E Olson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.

Authors:  Rosel Kretschmer-Kazemi Far; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

Review 3.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

4.  Evidence for U-tail stabilization of gRNA/mRNA interactions in kinetoplastid RNA editing.

Authors:  Donna J Koslowsky; Larissa Reifur; Laura E Yu; Weiqin Chen
Journal:  RNA Biol       Date:  2004-05-31       Impact factor: 4.652

5.  Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.

Authors:  M Homann; M Tabler; S Tzortzakaki; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

6.  Specificity of hammerhead ribozyme cleavage.

Authors:  K J Hertel; D Herschlag; O C Uhlenbeck
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

Review 7.  In vitro and in vivo action of antisense RNA.

Authors:  W Nellen; G Sczakiel
Journal:  Mol Biotechnol       Date:  1996-08       Impact factor: 2.695

Review 8.  Ribozymes. Their functions and strategies for their use.

Authors:  S A Gibson; E J Shillitoe
Journal:  Mol Biotechnol       Date:  1997-04       Impact factor: 2.695

9.  The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.

Authors:  R Hormes; M Homann; I Oelze; P Marschall; M Tabler; F Eckstein; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

10.  A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Authors:  M A Biasolo; A Radaelli; L Del Pup; E Franchin; C De Giuli-Morghen; G Palu
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.